|
Press Releases |
|
|
|
Friday, July 6, 2018 |
|
Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 At 18 Months |
Eisai Co., Ltd. and Biogen Inc. announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early Alzheimer's disease. more info >> |
|
Wednesday, July 4, 2018 |
|
Eisai Listed for 17th Consecutive Year in FTSE4GOOD Index Series |
Eisai Co., Ltd. announced today that it has been included in the FTSE4Good Index Series for the 17th consecutive year since its initial inclusion in 2002. more info >> |
|
Monday, July 2, 2018 |
|
エーザイ、第43回日本睡眠学会定期学術集会においてレンボレキサントの不眠障害を対象とした実薬比較臨床第III相試験の結果を口頭発表予定 |
エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫、以下 エーザイ)は、このたび、2018年7月11日~13日に札幌で開催される「第43回日本睡眠学会定期学術集会」におけるシンポジウム「睡眠学のための創薬研究」において、睡眠と覚醒を調節する薬剤として現在開発中のレンボレキサント(開発コード:E2006)の臨床第III相試験(SUNRISE 1試験)の結果を口頭発表します。 more info >> |
|
Eisai to Give Oral Presentation on Results of Phase III Head-to-Head Clinical Study of Lemborexant in Insomnia Disorder |
The symposium will report on the latest data on lemborexant from non-clinical research and clinical studies relating to insomnia, including the results of SUNRISE 1. more info >> |
|
Friday, June 22, 2018 |
|
Eisai Selected for Membership in MSCI Japan Empowering Women Index (WIN) |
Eisai Co., Ltd. announced today that it has been selected for the first time for membership in the MSCI Japan Empowering Women Index (WIN), an index developed for environmental, social and governance (ESG) investment. more info >> |
|
アッヴィとエーザイ、ヒト型抗ヒトTNFαモノクローナル抗体「ヒュミラ(R)」の新たな小児用製剤「ヒュミラ(R)皮下注20mgシリンジ0.2mL」を発売 |
アッヴィ合同会社とエーザイ株式会社は、ヒト型抗ヒトTNFαモノクローナル抗体「ヒュミラ(R)」(一般名:アダリムマブ<遺伝子組換え>、以下「ヒュミラ」)の新たな小児用製剤「ヒュミラ(R)皮下注20mgシリンジ0.2mL」について、6月15日に薬価基準に収載されたことを受け、本日、発売したことをお知らせします。 more info >> |
|
エーザイ、「MSCI日本株女性活躍指数(WIN)」の構成銘柄に選定 |
エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫)は、このたび環境、社会、ガバナンス(ESG)投資のために開発された「MSCI 日本株女性活躍指数(WIN)」の構成銘柄に、初めて選定されましたのでお知らせします。本指数は、年金積立金管理運用独立行政法人(GPIF)が、非財務価値であるESGの取り組みに基づいた投資を行うために選定する指数の一つとして採用されています。 more info >> |
|
Thursday, June 21, 2018 |
|
AbbVie and Eisai Announce the Launch of HUMIRA for Subcutaneous Injection 20 mg Syringe 0.2 mL |
AbbVie GK and Eisai Co., Ltd. announced that HUMIRA for Subcutaneous Injection 20 mg Syringe 0.2 mL, a new pediatric formulation of HUMIRA, a fully human anti-TNF-alpha monoclonal antibody formulation, has been launched today after being listed in the National Health Insurance reimbursement price list on June 15. more info >> |
|
Thursday, June 14, 2018 |
|
Eisai: Industry-Academia-Government Joint Development Agreement Concerning Nucleic Acid Drug Discovery Research |
Eisai Co., Ltd. announced today that its research subsidiary KAN Research Institute, Inc. has entered into an industry-academia-government joint research agreement with six joint research organizations concerning the "nucleic drug discovery research using novel nucleic acid synthesis and delivery technologies" research project represented by KAN. more info >> |
|
Wednesday, June 13, 2018 |
|
Eisai to Establish New Research Facility "Eisai Center for Genetics Guided Dementia Discovery" in Cambridge, Massachusetts, USA |
Eisai Co., Ltd. has announced that it has decided to establish the Eisai Center for Genetics Guided Dementia Discovery (G2D2), a new exploratory research facility focused on immuno-dementia based on human genetics, aimed at innovative drug discovery in the field of dementia, in Cambridge, Massachusetts, the United States. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
May 17, 2024 09:00: JST
|
|
|
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
May 17, 2024 08:00 HKT/SGT
|
|
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
May 16, 2024 22:00 HKT/SGT
|
|
|
加速大灣區互聯互通,內地乘客可在曹操出行下單大巴直達港澳
May 16, 2024 21:52 HKT/SGT
|
|
|
DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States
May 16, 2024 21:30 HKT/SGT
|
|
|
Horus: Million Dollar Air-Mail NFT Drop on Base
May 16, 2024 20:11 HKT/SGT
|
|
|
香港贸发局第三届「国际医疗健康周」正式展开
May 16, 2024 18:24 HKT/SGT
|
|
|
香港貿發局第三屆「國際醫療健康周」正式展開
May 16, 2024 18:15 HKT/SGT
|
|
|
HKTDC kicks off third International Healthcare Week
May 16, 2024 18:00 HKT/SGT
|
|
|
CleverTap's 2024 Market Research Report Unveils that Brands Implementing Higher AI Adoption See 4x Boost in Conversions
May 16, 2024 17:00 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 16, 2024 17:00 HKT/SGT
|
|
|
Q2 Metals Announces Re-Assay Results and Spring 2024 Exploration Plan for Cisco Lithium Property, James Bay Territory, Quebec, Canada
May 16, 2024 15:09 HKT/SGT
|
|
|
World CX Summit 2024: Steering the future of customer experience forward
May 16, 2024 15:05 HKT/SGT
|
|
|
Rover Announces and Closes $0.03 Unit Financing
May 16, 2024 05:00 HKT/SGT
|
|
|
New Research Increases Confidence in the Benefits of Vegan Diets for Dogs
May 16, 2024 05:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|